Showing results for "Eli Lilly"
industries
Medicare for Wegovy: Coverage Expands to Millions With Heart DiseaseMedicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.April 24, 2024
industries
Zepbound, Ozempic for Weight Loss: Safety, Effectiveness and Shortages, ExplainedObesity is among the world’s most common health conditions, but for years medicine had few effective approaches to offer short of surgery. That’s why there’s been so much excitement about a new class of drugs that’s helping patients shed dozens of pounds at far lower risk — and generating billions in revenue for pharmaceutical companies.April 18, 2024
industries
Ozempic Babies: Doctors Want Safety Data on Obesity Shots During PregnancyA surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant. That’s leading to questions about the safety of medications from Novo Nordisk A/S and Eli Lilly & Co. during pregnancy.April 18, 2024